IRB Review Services For Phase I Research

With experience overseeing thousands of Phase I studies in the US and Canada, Advarra’s institutional review board (IRB) understands the unique requirements of Phase I study design and conduct. Our dedicated team and processes are built to support your Phase I research needs.

Expertise to Ensure Appropriate, Efficient Reviews

• Significant experience in all Phase I study types, including first in human (FIH), bioavailability/ bioequivalence (BA/BE), single ascending dose (SAD), multiple ascending dose (MAD), food effect (FE), pharmacokinetic/pharmacodynamic (PK/ PD), drug-drug interaction (DDI), and more.
• Over 40 IRB members with extensive involvement conducting and reviewing Phase I research.
• Daily specialized IRB panels to review Phase I research and changes to previously approved research.